News | April 29, 2023
Evonik starts construction of new U.S. facility for pharmaceutical lipids
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
India's strategy against Covid was more effective than any other countries in the world
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
Valbenazine Capsules (RLD Ingrezza) had estimated annual sales of USD 1,235 million in the U.S. (IQVIA MAT December 2022).
Subscribe To Our Newsletter & Stay Updated
